Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study

被引：0
|
作者：
Taoufik Alsaadi
Reem Suliman
Vanessa Santos
Ibrahim Al Qaisi
Princess Carmina
Batool Aldaher
Shadi Haddad
Yazan Bader
机构：
[1] American Center for Psychiatry and Neurology,Department of Neurology
来源：
Neurology and Therapy | 2024年 / 13卷
关键词：
CGRP mAbs; Erenumab; Eptinezumab; Gepants; Migraine; Safety; Tolerability; UAE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：465 / 473
页数：8
相关论文
共 50 条
  • [1] Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
    Alsaadi, Taoufik
    Suliman, Reem
    Santos, Vanessa
    Al Qaisi, Ibrahim
    Carmina, Princess
    Aldaher, Batool
    Haddad, Shadi
    Bader, Yazan
    NEUROLOGY AND THERAPY, 2024, 13 (02) : 465 - 473
  • [2] Safety and tolerability of combining CGRP monoclonal antibodies with Gepants in patients with migraine: a retrospective study
    Alsaadi, T.
    Santos, V.
    Al Qaissi, I.
    Aldaher, B.
    Al Fardan, A.
    Bader, Y.
    Suliman, R.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [3] Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
    Messina, Roberta
    Huessler, Eva-Maria
    Puledda, Francesca
    Haghdoost, Faraidoon
    Lebedeva, Elena R.
    Diener, Hans-Christoph
    CEPHALALGIA, 2023, 43 (03)
  • [4] Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study
    Alex, Ashley
    Vaughn, Caila
    Rayhill, Melissa
    HEADACHE, 2020, 60 (10): : 2454 - 2462
  • [5] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [6] Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials
    Silvestro, Marcello
    Orologio, Ilaria
    Siciliano, Mattia
    Trojsi, Francesca
    Tessitore, Alessandro
    Tedeschi, Gioacchino
    Russo, Antonio
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (02) : 79 - 96
  • [7] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [8] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Charleston, Larry
    Talon, Brian
    Sullivan, Christine
    Anderson, Carlton
    Kymes, Steven
    Regnier, Stephane A. A.
    Soni-Brahmbhatt, Seema
    Nahas, Stephanie J. J.
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [9] Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
    Larry Charleston
    Brian Talon
    Christine Sullivan
    Carlton Anderson
    Steven Kymes
    Stephane A. Regnier
    Seema Soni-Brahmbhatt
    Stephanie J. Nahas
    The Journal of Headache and Pain, 24
  • [10] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
12345